8-K ·Filed Mar 11, 2026
8-K context-dependent: Items 5.02
Actionable Insight • Neutral
Monitor for release of full 8-K details or follow-up filings; absence of financial data prevents assessment of materiality. Given the small market cap ($37M), any leadership change could disproportionately affect investor sentiment.
Final — all horizons settled through T+60d
OTLK ▲ +84.56% at T+60d
NEUTRAL call ✓ call won +84.56% · α vs SPY +73.86% · entry $0.4210 → $0.7770
T+1d
-6.41%
call -6.41% · α -5.82%
$0.3940
settled 7mo ago
T+5d
-20.19%
call -20.19% · α -19.21%
$0.3360
settled 7mo ago
T+20d
-40.86%
call -40.86% · α -42.83%
$0.2490
settled 6mo ago
T+60d
+84.56%
call +84.56% · α +73.86%
$0.7770
settled 4mo ago
Price Chart
Loading chart...
Executive Summary
Analysis based on filing metadata only — document content was unavailable. The filing reports a departure or appointment of an officer or director (Item 5.02) and includes financial statements or exhibits (Item 9.01), but no specific details or financial impact can be determined without the full document.
Key Facts
- Filing is an 8-K report for Outlook Therapeutics, Inc. (OTLK)
- Items disclosed: 5.02 (Departure/Appointment of Directors or Officers) and 9.01 (Financial Statements and Exhibits)
- No document content available to assess specifics of executive change or nature of exhibits
Financial Impact
Not specified
Risk Factors
- Material executive departure or governance issue may be undisclosed due to missing content
- Potential delay in financial reporting or material agreement not captured
Market Snapshot
Exchange
Nasdaq
Investment Themes
Biotech & Drug Discovery
Documents Analyzed
Report based on filing metadata.
34 reports for OTLK
79% Hit rate best @ T+20▲ +306.25%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Aug 14, 2026 7w ago | 8-K | $0.7564 $0.6379 | ▲ +15.67% | ▲ +13.67% | $0.5778 (+23.61%) |
Aug 14, 2026 7w ago | 424B5 | $0.7564 $0.6379 | ▲ +15.67% | ▲ +13.67% | $0.5778 (+23.61%) |
Aug 14, 2026 7w ago | 8-K | $0.7564 $0.6379 | ▲ +15.67% | ▲ +13.67% | $0.5778 (+23.61%) |
Aug 14, 2026 7w ago | Press Release | $0.7564 $0.6379 | ▼ −15.67% | ▼ −13.67% | $0.5778 (−23.61%) |
Aug 13, 2026 7w ago | Press Release | $0.8888 $0.6600 | ▲ +25.74% | ▲ +24.00% | $0.5778 (+34.99%) |
Aug 12, 2026 7w ago | 8-K | $0.8888 $0.6600 | ▲ +25.74% | ▲ +24.00% | $0.5778 (+34.99%) |
Jul 24, 2026 9w ago | 8-K | $1.07 $0.6090 | ▼ −42.82% | ▼ −46.12% | $0.5778 (−45.75%) |
Jul 24, 2026 10w ago | Press Release | $1.41 $0.6472 | ▼ −53.94% | ▼ −57.56% | $0.5778 (−58.88%) |
Jul 23, 2026 10w ago | 8-K | $1.41 $0.6472 | ▼ −53.94% | ▼ −57.56% | $0.5778 (−58.88%) |
Jul 22, 2026 10w ago | EFFECT | $1.34 $0.6901 | ▼ −48.50% | ▼ −51.40% | $0.5778 (−56.88%) |
Showing 10 of 34
US Market Status
Market Open — Closes in 47m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access